Medtronic (MDT) Cash & Current Investments (2013 - 2026)
Medtronic (MDT) posted Cash & Current Investments of $9.2 billion for Q2 2026, up 9.98% sequentially from $8.4 billion in Q1 2026, and up 2.84% YoY from $9.0 billion in Q2 2025.
Medtronic (MDT) Cash & Current Investments (2013 - 2026) Analysis & Trends
Medtronic has reported Cash & Current Investments for 14 years, with the latest figure at $9.2 billion in Q2 2026.
- Quarterly Cash & Current Investments rose 2.84% year-over-year to $9.2 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $9.2 billion (up 2.84% YoY) and the FY2026 annual result came in at $9.2 billion, up 2.84% from the prior year.
- Cash & Current Investments grew to $9.2 billion in Q2 2026 per MDT's latest filing, from $8.4 billion in the prior quarter.
- Over five years, Cash & Current Investments peaked at $11.4 billion in Q4 2022 and troughed at $7.7 billion in Q4 2023.
- A 5-year average of $8.9 billion and a median of $8.3 billion in 2024 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2023 and 2025: Cash & Current Investments slumped 32.34% in 2023, then increased 11.99% in 2025.
- Over 5 years, Cash & Current Investments stood at $11.4 billion in 2022, then plunged by 32.34% to $7.7 billion in 2023, then gained by 3.3% to $8.0 billion in 2024, then gained by 4.23% to $8.3 billion in 2025, then climbed by 10.72% to $9.2 billion in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $9.2 billion, $8.4 billion, and $8.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 9.22 Bn |
| Jan 23, 2026 | 8.38 Bn |
| Oct 24, 2025 | 8.33 Bn |
| Jul 25, 2025 | 8.12 Bn |
| Apr 25, 2025 | 8.97 Bn |
| Jan 24, 2025 | 7.92 Bn |
| Oct 25, 2024 | 7.99 Bn |
| Jul 26, 2024 | 7.84 Bn |
| Apr 26, 2024 | 8.01 Bn |
| Jan 26, 2024 | 8.32 Bn |
| Oct 27, 2023 | 7.73 Bn |
| Jul 28, 2023 | 7.88 Bn |
| Apr 28, 2023 | 7.96 Bn |
| Jan 27, 2023 | 11.14 Bn |
| Oct 28, 2022 | 11.43 Bn |
| Jul 29, 2022 | 8.87 Bn |
| Apr 29, 2022 | 10.57 Bn |
| Jan 28, 2022 | 11.22 Bn |
| Oct 29, 2021 | 10.67 Bn |
| Jul 30, 2021 | 10.60 Bn |